We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+4.84%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$191B
AUM Growth
+$34.6B
(+22%)
Cap. Flow
+$29.9B
Cap. Flow
% of AUM
15.69%
Top 10 Holdings %
Top 10 Hldgs %
11.5%
Holding
3,667
New
211
Increased
2,098
Reduced
1,163
Closed
105
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$905M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$786M |
| 3 |
NVIDIA
NVDA
|
+$736M |
| 4 |
Centene
CNC
|
+$642M |
| 5 |
Apple
AAPL
|
+$451M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Molina Healthcare
MOH
|
+$415M |
| 2 |
Intel
INTC
|
+$329M |
| 3 |
General Motors
GM
|
+$237M |
| 4 |
DoorDash
DASH
|
+$225M |
| 5 |
Intuit
INTU
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.3% |
| 2 | Financials | 15.19% |
| 3 | Healthcare | 12.58% |
| 4 | Consumer Discretionary | 12.42% |
| 5 | Industrials | 12.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Repligen
RGEN
$9.45B
| $1.42M | ﹤0.01% |
8,648
-568
| -6% | -$89K |
|
|
ORC
2352
Orchid Island Capital
ORC
$1.32B
| $1.42M | ﹤0.01% |
196,612
+92,810
| +89% | +$676K |
|
2353
Ribbon Communications
RBBN
$372M
| $1.42M | ﹤0.01% |
491,471
+322,364
| +191% | +$1.04M |
|
|
KREF
2354
KKR Real Estate Finance Trust
KREF
$493M
| $1.41M | ﹤0.01% |
171,674
-206,140
| -55% | -$1.74M |
|
2355
U-Haul Holding Co Series N
UHAL.B
$12.7B
| $1.41M | ﹤0.01% |
30,153
+3,922
| +15% | +$191K |
|
2356
Construction Partners
ROAD
$6.9B
| $1.41M | ﹤0.01% |
12,969
-477
| -4% | -$53.7K |
|
2357
Paysafe
PSFE
$352M
| $1.41M | ﹤0.01% |
173,678
-149,663
| -46% | -$1.45M |
|
2358
JetBlue
JBLU
$2.19B
| $1.4M | ﹤0.01% |
308,761
+192,385
| +165% | +$877K |
|
2359
Medifast
MED
$130M
| $1.4M | ﹤0.01% |
131,509
-179,310
| -58% | -$2.15M |
|
2360
Covenant Logistics
CVLG
$865M
| $1.4M | ﹤0.01% |
63,651
+206
| +0.3% | +$4.32K |
|
2361
Vanguard US Multifactor ETF
VFMF
$930M
| $1.4M | ﹤0.01% |
9,290
+1,291
| +16% | +$189K |
|
2362
Helios Technologies
HLIO
$2.66B
| $1.4M | ﹤0.01% |
26,123
+2,689
| +11% | +$145K |
|
2363
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.43B
| $1.39M | ﹤0.01% |
9,855
-358
| -4% | -$50.7K |
|
2364
Renasant Corp
RNST
$4B
| $1.39M | ﹤0.01% |
39,440
-8,419
| -18% | -$298K |
|
2365
E.W. Scripps
SSP
$310M
| $1.39M | ﹤0.01% |
347,829
-110,575
| -24% | -$372K |
|
2366
Tecnoglass Holdings Inc.
TGLS
$1.86B
| $1.38M | ﹤0.01% |
27,479
+3,345
| +14% | +$183K |
|
2367
Dyne Therapeutics
DYN
$4.85B
| $1.38M | ﹤0.01% |
70,659
-71,216
| -50% | -$1.35M |
|
2368
Werner Enterprises
WERN
$2.31B
| $1.38M | ﹤0.01% |
45,991
-42
| -0.1% | -$1.15K |
|
2369
State Street SPDR Portfolio Corporate Bond ETF
SPBO
$2.1B
| $1.38M | ﹤0.01% |
46,893
| – | – |
|
2370
James Hardie Industries
JHX
$17.9B
| $1.37M | ﹤0.01% |
66,235
+8,443
| +15% | +$169K |
|
2371
ICU Medical
ICUI
$4.58B
| $1.36M | ﹤0.01% |
9,549
+808
| +9% | +$108K |
|
2372
Fortuna Silver Mines
FSM
$3.21B
| $1.36M | ﹤0.01% |
+138,788
| New | +$1.25M |
|
2373
JPMorgan US Momentum Factor ETF
JMOM
$2.64B
| $1.36M | ﹤0.01% |
19,901
+10,508
| +112% | +$716K |
|
2374
Procept Biorobotics
PRCT
$1.26B
| $1.35M | ﹤0.01% |
43,058
-23,283
| -35% | -$772K |
|
2375
Celanese
CE
$4.75B
| $1.35M | ﹤0.01% |
32,036
-18,961
| -37% | -$773K |
|
Similar funds
AQR Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, AQR Capital Management held 3,667 positions worth $191B, up 22% from $156B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
AQR Capital Management deployed $29.9B of net new capital in Q4 2025, opening 211 new positions and adding to 2,098 existing holdings. Its largest new stake was Celestica: 1,066,543 shares worth $315M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Molina Healthcare, an estimated $415M trimmed.
- AQR Capital Management's largest Q4 2025 buy was Celestica: 1,066,543 shares worth $315M.
- AQR Capital Management added most to Atlassian in Q4 2025, an estimated $905M increase.
- AQR Capital Management's biggest Q4 2025 reduction was Molina Healthcare, cutting an estimated $415M.
- AQR Capital Management fully exited Light & Wonder in Q4 2025, selling an estimated $70.7M.
- AQR Capital Management's ten largest holdings make up 12% of its $191B portfolio in Q4 2025.
- AQR Capital Management opened 211 new positions and closed 105 in Q4 2025.
- AQR Capital Management's portfolio value rose 22% quarter-over-quarter to $191B.
Based on AQR Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.